Publication

Diabetes Research and Resource Sharing During the COVID-19 Pandemic: A Systematic Review and Experience from an Academic/Non-profit Resource Website

Downloadable Content

Persistent URL
Last modified
  • 06/25/2025
Type of Material
Authors
    Andrea M Yeung, Diabetes Technology Society, BurlingameSudha Dirisanala, Northeast Georgia Medical Center, GainesvilleAmalia Abraham, Emory UniversityJingtong Huang, Diabetes Technology Society, BurlingameGrayson M Brennan, Georgia State UniversityMaría Agustina Urrutia, Emory UniversityJesica D Baran, University of WashingtonKevin T Nguyen, Diabetes Technology Society, BurlingameNicole Y Xu, University of CaliforniaTrisha Shang, Case Western Reserve UniversityJennifer Y Zhang, Diabetes Technology Society, BurlingameDavid C Klonoff, Mills-Peninsula Medical Center, San MateoGeorgia M Davis, Emory UniversityFrancisco J Pasquel, Emory University
Language
  • English
Date
  • 2023-01-01
Publisher
  • Emory University Libraries
Publication Version
Copyright Statement
  • © 2023 Diabetes Technology Society
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 17
Issue
  • 5
Start Page
  • 1284
End Page
  • 1294
Grant/Funding Information
  • The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This effort was partially supported by NIDDK of the NIH under the award number P30DK111024, Georgia Diabetes Translation Research Center (GDTRC) project “The Preparedness Cycle in the Care of People with Diabetes During the COVID-19 Pandemic and Future Outbreaks”.
Abstract
  • Background: The magnitude of the response of the diabetes professional community to the COVID-19 pandemic is not known. We aimed to examine diabetes technology research trends and resources offered by professional organizations during this period. Methods: We explored patterns of the response from the professional diabetes community to the pandemic by (1) systematically searching for articles related to diabetes, COVID-19, and diabetes technologies; (2) examining publication trends of research protocols (clinicaltrials.gov) and preprints (medRxiv); and (3) reviewing online resources from professional organizations including our website (COVIDinDiabetes.org; an Emory University—Diabetes Technology Society collaboration). Results: We identified 492 articles published between December 2019 and December 2022 meeting our inclusion criteria. Telemedicine and continuous glucose monitoring were the most common reported technologies from most parts of the world. The largest number of preprint articles was published in 2020, with a decline in 2021 and 2022. The number of research protocols related to COVID-19 was the highest in 2020 and declined in 2021 and 2022. Resources from organizations included protocols adapted to treat patients with diabetes and COVID-19, training programs, emergency preparedness, and literature on diabetes and COVID-19. On our website (COVIDinDiabetes.org), there were 12 236 visits and 18 149 pageviews, with 1.6 actions per visits, with most visits coming from North America (N = 7233, 54.2%), South America (N = 2663, 21.8%), and Europe (N = 1219). Conclusions: We conclude that the COVID-19 pandemic promoted unprecedented global research productivity related to diabetes and COVID-19 and that the transition to the use of technology resources has been evident during this period.
Author Notes
Keywords
Research Categories
  • Health Sciences, Public Health
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items